Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
about
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.Novel and emerging targeted-based cancer therapy agents and methods.Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.Ibrutinib-A double-edge sword in cancer and autoimmune disorders.Targeted Covalent Inhibitors for Drug Design.Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.
P2860
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@ast
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@en
type
label
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@ast
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@en
prefLabel
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@ast
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@en
P2860
P356
P1476
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
@en
P2093
P2860
P304
P356
10.4155/FMC.14.24
P577
2014-04-01T00:00:00Z